- SEK12.88bn
- SEK12.36bn
- SEK1.54bn
Brief: BioGaia Q3 Net Income SEK 110.2 Million
Sweden's BioGaia Q2 sales rises on segment growth
Brief: BioGaia Q2 Net Income SEK 103.2 Million
Sweden's BioGaia Q1 sales, operating profit rise
Brief: BioGaia Q1 Net Income SEK 79.4 Million
Brief: Biogaia Research Confirms Effectiveness Longevityguard Technology
Brief: BioGaia Exercises Option To Acquire Remaining Shares In Nutraceutics
Brief: BioGaia Extends Distribution Partnership With Ewopharma
Sweden's BioGaia Q4 sales rise on organic pediatric growth
Brief: Biogaia Q4 Net Income Up At Sek 98.8 Mln
BioGaia's prelim Q4 sales rise 21%, margins expand
Brief: BioGaia Q4 EBIT Margin 27%
Brief: BioGaia Q3 Net Income SEK 65.9 Million
Brief: Biogaia Establishes Own Distribution In Germany, Austria
Brief: Biogaia's Probiotic Can Help Prevent Antibiotic-Associated Diarrhea In Children
Brief: Biogaia Says Mauricio Graber Elected As Chairman Of Board
Brief: Mauricio Graber Proposed As New Chairman Of Biogaia Board
Brief: BioGaia Q2 Net Income SEK 87.9 Million
Brief: Biogaia Launches Subsidiary For Microbiome Products